To be diagnosed with dyslipidemia, which of the following lipid profile abnormalities is typically considered in the diagnostic criteria?

A. In symptomatic heart failure, it is physiologically impossible for the LVEDP to remain within a normal range because the heart cannot effectively empty. The residual volume after systole increases, which naturally raises the pressure at the end of the next filling phase. Maintaining a normal pressure range would imply that the heart's pumping efficiency is still preserved.

B. Heart failure is characterized by decreased ventricular compliance and impaired relaxation, which leads to an increase in pressure for any given volume. Compliance refers to the ability of the heart chamber to stretch; in failure, the walls become stiff or overstretched. Therefore, LVEDP rises significantly as the ventricle resists the incoming blood flow from the left atrium.

C. While LVEDP and cardiac output are related through the Frank-Starling mechanism, saying they are strictly inversely proportional is a physiological oversimplification. In the failing heart, the curve flattens, meaning that increasing LVEDP no longer results in an increased cardiac output. Eventually, the heart reaches a point where higher filling pressures actually lead to a further decline in stroke volume.

D. LVEDP increases because the weakened myocardium cannot eject blood efficiently, leading to high pressures that back up into the pulmonary veins. This increased hydrostatic pressure forces fluid into the alveolar spaces, which is the primary mechanism for pulmonary congestion and edema. Elevated LVEDP is a central hemodynamic finding that explains the shortness of breath in heart failure.

A. An estimated glomerular filtration rate (eGFR) between 30 and 59 mL/min signifies Stage 3 chronic kidney disease, indicating a moderate reduction in renal function. At this level, patients often begin to manifest complications such as secondary hyperparathyroidism, anemia, and early bone disease. It represents a more advanced decline than Stage 2.

B. The eGFR range of 15 to 29 mL/min is classified as Stage 4 chronic kidney disease, which is a severe reduction in kidney function. Patients at this stage are typically being prepared for renal replacement therapy, such as dialysis or transplantation. This reflects significant nephron loss and a high risk for systemic metabolic acidosis.

C. Stage 2 chronic kidney disease is defined by an eGFR of 60 to 89 mL/min, representing a mild reduction in renal filtration. To meet the diagnostic criteria for CKD at this stage, there must also be evidence of structural kidney damage, such as persistent albuminuria. It indicates the early stages of progressive renal impairment.

D. An eGFR ≥90 mL/min is considered Stage 1 chronic kidney disease if there is concurrent evidence of kidney damage, such as proteinuria or structural abnormalities. This value represents normal or high filtration capacity. In the absence of other markers of damage, this range is simply considered normal physiological renal function for most adults.